Page 1 2 ... 30 40 50 ... 200 ... NEXT>>
[ July 30, 2014 | Author: Admin | Views: 72557 | Weather: | Mood: normal]

Yahoo! Inc. (YHOO) is often overlooked by individual investors who tend to focus on hotter trending tech names such as Google (GOOG) or Facebook (FB). However, this shouldn’t be the case as the 3 month average volume for Yahoo (largely from institutional investors) has been 17 million shares, with a market cap of $27.6 billion, and a share price that is up 80.76% in its last 12 months (as of the end of Thursday, 22nd August 2013). With an increase like that, is it possible that the share price is still undervalued? I believe so. A good indicator is the recent news from ComScore, which indicates that Yahoo topped Google in the U.S. for Web Traffic in July, 2013 (the first time since May, 2011). The past eighteen years for Yahoo! Inc., haven’t exactly been smooth sailing, and the recent efforts from Yahoo certainly deserve applause as they’ve been steadily … Continue reading

[ July 29, 2014 | Author: Admin | Views: 74326 | Weather: | Mood: normal]

You’d think a story in The Wall Street Journal about executives fleeing JPMorgan Chase (NYSE: JPM  ) might put pressure on its stock. But by the looks of it, that doesn’t appear to be the case, as shares of the nation’s largest bank by assets were briefly higher in intraday trading despite just such an account. According to the Journal’s blog MoneyBeat, two former high-ranking JPMorgan executives are in the process of poaching former direct reports to fill positions at the companies they now run. Charlie Scharf, the current CEO of Visa and one-time Dimon ally who followed him from Citigroup to BankOne and then to JPMorgan, has purportedly lured Ryan McInerney away from the bank to serve as Visa’s president in charge of global client organization. McInerney had been the CEO of consumer banking at JPMorgan and served on the executive committee. In addition, JPMorgan’s recently departed co-COO Frank Bisignano, … Continue reading

[ July 29, 2014 | Author: Admin | Views: 61079 | Weather: | Mood: normal]

We’re into the heart of earnings season, and several of the medical device industry’s biggest players have already reported quarterly results. Johnson & Johnson (NYSE: JNJ  ) led off among the biggest players, with fellow diversified health care firm Abbott Labs (NYSE: ABT  ) and more concentrated company St. Jude Medical (NYSE: STJ  ) following suit last week. In that time, a few key trends have stood out that investors should take note of particularly before Boston Scientific’s (NYSE: BSX  ) earnings emerge this Thursday. Fool contributor Dan Carroll and health care analyst Max Macaluso discuss how the above companies fared this earnings season, and if the trends we’ve seen will come to shape Boston Scientific’s earnings as well later this week. Is bigger really better?Involved in everything from baby powder to biotech, Johnson & Johnson’s critics are convinced that the company is spread way too thin. If you want to know if J&J … Continue reading

[ July 29, 2014 | Author: Admin | Views: 78294 | Weather: | Mood: normal]

Market Outlook: For Friday, the market all boils down to Non-farm Payrolls and the Unemployment Rate. After a weak ADP Employment Change number on Wednesday followed by stronger than expected Initial Jobless Claims on Thursday, Friday’s NFP report will be very important to market direction for the day and likely next week. At the same time, the weak move on Wednesday for the markets likely priced in some expectations of a miss for Friday’s report. Additionally, the positive news from the Bank of Japan to introduce a new monetary policy similar to the Fed’s QE helped markets rally Thursday. That news should help balance weakness in employment as well. Therefore, we would look for a hushed move lower on any weakness in NFP and a very positive reaction if NFP surprises and comes close to expectations or beats them. Look for a 20-40 point drop on the Dow Jones (DIA) … Continue reading

[ July 29, 2014 | Author: Admin | Views: 84371 | Weather: | Mood: normal]

Life insurer Prudential Financial, Inc. (PHR) reported stronger than expected third quarter earnings driven by higher fees in the variable annuity business and increased earnings in its International segment. The company also benefitted from a robust equity market and higher interest rates. From Diamond Hill Capital (Trades, Portfolio)’s Fourth Quarter 2013 Commentary. Also check out: Diamond Hill Capital Undervalued Stocks Diamond Hill Capital Top Growth Companies Diamond Hill Capital High Yield stocks, and Stocks that Diamond Hill Capital keeps buying Currently 0.00/512345 Rating: 0.0/5 (0 votes) Subscribe via Email Subscribe RSS Top 10 Valued Companies To Buy For 2015: Tupperware Corporation(TUP) Tupperware Brands Corporation operates as a direct seller of various products across a range of brands and categories through an independent sales force. The company engages in the manufacture and sale of kitchen and home products, and beauty and personal care products. It offers preparation, storage, and serving solutions … Continue reading